Biz Break: Gilead on a Roll Even Before Breakthrough Hepatitis C Drug's Effects

Published February 7, 2014

Biz Break: Gilead on a roll even before breakthrough hepatitis C drug's effects
Analysts on average expect $ 3.14 billion in Sovaldi sales in 2014, according to Bloomberg News, but projections have ranged as high as $ 7 billion for the drug, which costs more than $ 80,000 for a full course. … would step down from his chairman post …
Read more on Tri-Valley Herald

Sea survivor's family rejoices to regain lost son
"The sea was his thing," Alvarenga's father, Jose Ricardo Orellana, 65, said Tuesday. Orellana, who owns … Alvarenga's family reacted with joy after two phone calls from their long lost son, who told them he was getting medical treatment and food in …
Read more on San Francisco Chronicle

Related Cost Drug Rehab San Jose Information…